Oligodendrogliomas Completed Phase 2 Trials for Everolimus (DB01590)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs